Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;50(7):572-582.
doi: 10.4070/kcj.2019.0385. Epub 2020 Mar 17.

Sinus of Valsalva Thrombosis Detected on Computed Tomography after Transcatheter Aortic Valve Replacement

Affiliations

Sinus of Valsalva Thrombosis Detected on Computed Tomography after Transcatheter Aortic Valve Replacement

Su Jin Lim et al. Korean Circ J. 2020 Jul.

Abstract

Background and objectives: Leaflet thrombosis after transcatheter aortic valve replacement (TAVR) has been reported recently, whereas thrombus formation in sinus of Valsalva has yet to be fully evaluated. This study describes clinical and cardiac computed tomography (CT) findings of patients with sinus of Valsalva thrombosis.

Methods: Between March 2011 and Aug 2019, 192 patients underwent cardiac CT after TAVR. After a retrospective review of CT images, 9 patients (82 years, male:female=2:7) who had sinus of Valsalva thrombosis identified by cardiac CT were selected for this study. Patient demographics, interval between TAVR and cardiac CT scan, location and CT attenuation of sinus of Valsalva thrombosis, and presence of concurrent leaflet thrombosis were evaluated.

Results: The median interval between TAVR and cardiac CT was 11 days. Sinus of Valsalva thrombosis was frequently detected in the non-coronary sinus (89%, 8/9), and predominantly located in the bottom of the sinus extending upward towards the sinotubular junction. Three patients had concomitant leaflet thrombosis, and 3 patients had subclinical embolic stroke noted on brain magnetic resonance imaging. All patients had been prescribed aspirin and clopidogrel after TAVR for at least 6 months without anticoagulants.

Conclusions: Cardiac CT after TAVR can detect sinus of Valsalva thrombosis, and attention should be paid to this potential source of subsequent systemic embolization.

Keywords: Aortic valve stenosis; Multidetector computed tomography; Sinus of valsalva; Thrombosis; Transcatheter aortic valve replacement.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

Figures

Figure 1
Figure 1. Multiplanar-reconstructed CT images of sinus of Valsalva thrombosis in the 8 patients.
CT = computed tomography.
Figure 2
Figure 2. An 85-year-old woman diagnosed with severe aortic stenosis. (A, B) Diffusion-weighted magnetic resonance images and (C) FLAIR image obtained 9 days after TAVR. Hyperintense acute infarction lesions can be noted in right parietal and left occipital lobes. (D, E) Cardiac gated CT obtained 177 days after TAVR shows low attenuation thrombus in the non-coronary sinus of Valsalva, and (F) FLAIR image acquired at the same time shows new cortical/subcortical hyperintensity consistent with prior embolic infarction.
CT = computed tomography; FLAIR = fluid attenuated inversion recovery; TAVR = transcatheter aortic valve replacement.
Figure 3
Figure 3. A 79-year-old woman who underwent TAVR. (A, B) Diffusion-weighted magnetic resonance images and (C) FLAIR image obtained 3 days after TAVR. Hyperintense acute infarction lesions were noted in the right frontal lobe. (D, E) Cardiac gated CT obtained 184 days after TAVR shows low attenuation thrombus in the non-coronary sinus of Valsalva, and (F) FLAIR image acquired at the same time shows new subcortical white signal intensity consistent with prior embolic infarction.
CT = computed tomography; FLAIR = fluid attenuated inversion recovery; TAVR = transcatheter aortic valve replacement.

References

    1. Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2485–2491. - PubMed
    1. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–2484. - PubMed
    1. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–1331. - PubMed
    1. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–2198. - PubMed
    1. Thyregod HG, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–2194. - PubMed